When the patients met the innovators at MedCity CONVERGE
Christina Hernandez Sherwood, eMed Editor, MedCity News
At MedCity CONVERGE, a national, executive-level summit on healthcare innovation in Philadelphia last week, local AARP members were on hand to learn about the two-dozen companies represented in the Pfizer Startup Showcase.
When asked which startups they believed would help solve today's health problems, AARP members singled out the following companies:
Quick: A biomedical mobile application company specializing in diagnostic and measuring products that incorporate smart devices. Quick is creating noninvasive personal testing platforms that are painless, bloodless, and mobile. Quick's most strategic area of focus is monitoring patients with diabetes.
Vimty: An online tool to help patients and their families understand, collaborate, and make decisions for the last stages of their lives. Vimty simplifies both the topic and the process, enabling members to make decisions as well as create, notarize and store the digital advanced directive all in one sitting.
Neurotrack: This technology can diagnose Alzheimer's disease three to six years before symptoms appear, creating the potential to transform diagnosis and treatment. Based on research and tested during a six-year longitudinal study, Neurotrack's computer-based cognitive/visual test gives pharmaceutical companies and research organizations the tools to recruit truly qualified candidates for clinical trials and more effectively measure drug efficacy, speeding up drug discovery and development.
The full video is available below: